Form D · Biotechnology

Precision Nanosystems Inc.

Vancouver, A1 · CIK 0001654441

Offering snapshot reported Nov 14, 2019 · SEC filing

Reported sold
$6M
Offering amount: $6M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 19, 2019
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3M$6MAug 30, 2019: $2,980,168.00Aug 30, 2019Nov 14, 2019: $5,999,999.00Nov 14, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$2,980,168 → $5,999,999
  • Reported investors7 → 13

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 14, 2019Amendment$5,999,999$3,019,831vs Aug 30, 201913SEC filing
Aug 30, 2019Initial$2,980,168No comparison7SEC filing
May 29, 2018Initial$5,942,777No comparison8SEC filing
Nov 3, 2016Amendment$13,402,748$6,115,991vs Sep 30, 20157SEC filing
Sep 30, 2015Initial$7,286,757No comparison7SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-347792
Series C Preferred Stock, together with underlying common shares

Source: Form D, filed Nov 14, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Andrew Booth Director, Executive
Mira Chaurushiya Director
Deval Lashkari Director
Daniel Nixon Director
Euan Clark Ramsay Executive
Steve Reichenbach Executive
Andrew J. Schwab Director
Robert James Taylor Director, Executive
R. James Taylor Director, Executive
Joe Victor Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
50 655 West Kent Avenue North
Vancouver, A1, V6P 6T7